This follows Sun Pharma's recent recall of 54,960 bottles of Mesalamine extended-release capsules in the American market. Mesalamine delayed-release capsules are indicated for the treatment of ...
Gujarat: TARO Pharmaceuticals Inc., a subsidiary of Sun Pharmaceutical Industries Limited, has entered into an agreement with ...
Shares of Sun Pharmaceutical Industries Ltd. 524715 advanced 2.01% to 1,834.05 Indian rupees Thursday, on what proved to be ...
In a separate disclosure, the USFDA stated that Mumbai-based Sun Pharma is recalling 1,920 bottles of Dofetilide Capsules, which are used to treat irregular heartbeat. The affected lot has been ...